Imaxio   Report issue

For profit Phase 1
Founded: Lyon France (2000)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2013
NCT01879163
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

mva85a-imx313 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1